TAO Synergies TAOX
NASDAQ TAOX
$3.55 +0.16 (+4.88%)
At close: Oct 21, 2026 · 4:00 PM EDT

TAO Synergies (TAOX) EBIT Margin (2025 - 2026)

Updated

TAO Synergies' EBIT Margin came in at -1770.63% for Q2 2026, up 74853.12 percentage points from -76623.75% a year earlier but down 1431.67 percentage points from the prior quarter.

Analysis

TAO Synergies (TAOX) EBIT Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, TAO Synergies reported EBIT Margin of -1013.48%; for FY2025, it came in at -3025.19%.

  • The five-year range for quarterly EBIT Margin is -76623.75% (Q2 2025) to -338.95% (Q1 2026).
  • Business Quant data shows TAOX's EBIT Margin at -338.95% (Q1 2026), -3426.06% (Q4 2025) and -884.84% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 TAO Synergies 26.38 Mn 433,385.79 - -1,770.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,770.63%
Mar 31, 2026 -338.95%
Dec 31, 2025 -3,426.06%
Sep 30, 2025 -884.84%
Jun 30, 2025 -76,623.75%
API Access

TAO Synergies EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=TAOX&period=max&api_key=YOUR_API_KEY